Kang Xiaoping, Wu Weili, Zhang Chuntao, Liu Licheng, Feng Huahua, Xu Lizhi, Zheng Xin, Yang Honglei, Jiang Yongqiang, Xu Bianli, Xu Jin, Yang Yinhui, Chen Weijun
State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Dongdajie Road 20, Beijing 100071, China.
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, No. 1 Beichen West Road, Beijing, Chaoyang District, 100101, China.
J Virol Methods. 2014 Sep;206:140-3. doi: 10.1016/j.jviromet.2014.01.026. Epub 2014 May 29.
The first case of avian influenza A/H7N9 infection was reported in Shanghai in mid-February, 2013; by May 1, 2013, it had infected 127 people and caused 26 deaths in 10 provinces in China. Therefore, it is important to obtain reliable epidemiological data on the spread of this new infectious agent, a need that may be best met by the development of novel molecular methods. Here, a new method was described for the detection of avian influenza A/H7N9 using real-time reverse transcription-polymerase chain reaction (rRT-PCR). Using serial dilutions of avian influenza A H7N9 cultures, the detection limit of the assay was determined to be approximately 3.2×10(-4) HAUs (hemagglutination units) for the H7 gene and 6.4×10(-4) HAUs for N9 gene. In tests of serial dilutions of in vitro-transcribed avian influenza A H7 and N9 gene RNA, positive results were obtained for target RNA containing at least three copies of the H7 gene and six copies of the N9 gene. Thirteen throat swabs from H7N9 patients were tested; all tested positive in the assay. Specificity was evaluated by testing 18 other subtypes of influenza viruses; all tested negative. A total of 180 throat swabs from patients infected with influenza virus, including 60 from patients infected with seasonal influenza A/H1N1 virus, 60 from patients infected with pandemic influenza A/H1N1/2009 virus, 30 from patients infected with seasonal influenza A/H3N2 virus and 30 from patients infected with influenza B virus, were also tested; all tested negative.
2013年2月中旬,上海报告了首例甲型H7N9禽流感感染病例;截至2013年5月1日,该病毒已在中国10个省份感染了127人,并导致26人死亡。因此,获取有关这种新型传染因子传播的可靠流行病学数据非常重要,而开发新型分子方法可能最能满足这一需求。在此,描述了一种使用实时逆转录-聚合酶链反应(rRT-PCR)检测甲型H7N9禽流感的新方法。使用甲型H7N9禽流感培养物的系列稀释液,该检测方法对H7基因的检测限确定为约3.2×10(-4)血凝单位(HAUs),对N9基因的检测限为6.4×10(-4)HAUs。在体外转录的甲型H7和N9基因RNA系列稀释液的测试中,对于至少包含三个H7基因拷贝和六个N9基因拷贝的靶RNA获得了阳性结果。对13份H7N9患者的咽拭子进行了检测;所有样本在该检测中均呈阳性。通过检测其他18种流感病毒亚型评估特异性;所有检测均为阴性。还对180份流感病毒感染患者的咽拭子进行了检测,其中包括60份季节性甲型H1N1流感病毒感染患者的样本、60份甲型H1N1/2009大流行性流感病毒感染患者的样本、30份季节性甲型H3N2流感病毒感染患者的样本和30份乙型流感病毒感染患者的样本;所有检测均为阴性。